Unibest
← Back to patent-cliff list

CAS 603-11-2

3-nitrophthalic acid

Codes: APER-006, AZIL-001, CAND-001, LUMI-001

Application context (from source-drug indications)

Plaque psoriasisApremilastBehçet's syndromeApremilastOral ulcerApremilastPsoriasisApremilastPsoriatic arthritisApremilastHypertensionAzilsartan Medoxomil Potassium/ChlorthalidoneEssential hypertensionAzilsartan Medoxomil Potassium/ChlorthalidoneHypertensionAmlodipine Besylate/Candesartan CilexetilEssential hypertensionAzilsartan Medoxomil PotassiumHypertensionAzilsartan Medoxomil PotassiumHypertensionCandesartan CilexetilHeart failureCandesartan CilexetilEssential hypertensionCandesartan CilexetilMigraineCandesartan CilexetilCOVID-19Candesartan CilexetilManiaCandesartan Cilexetil免疫紊乱Luminol sodiumPsoriasisLuminol sodiumCOVID-19Luminol sodiumPlaque psoriasisLuminol sodium

Source drugs (routes using this intermediate)

DrugTierExpiry
ApremilastTier B — Position early2028
Azilsartan Medoxomil Potassium/ChlorthalidoneTier C — Watch / trade-
Amlodipine Besylate/Candesartan CilexetilTier C — Watch / trade-
Azilsartan Medoxomil PotassiumTier C — Watch / trade-
Candesartan CilexetilTier B — Position early-
Luminol sodiumTier C — Watch / trade-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Luminol sodiumOptimised routesteps: 3total yield: /
Luminol sodiumOptimised routesteps: 3total yield: 182 g (Luminol)

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.